The lung puncture needle, as a key instrument in the fields of respiratory intervention and tumor diagnosis, has witnessed its market growth closely linked to the rising incidence of lung cancer, the popularization of the concept of early diagnosis and treatment, and the iterative development of precision medical technologies. This specialized market segment is characterized by being driven by technological innovation, accelerating domestic substitution, and integrating deeply with imaging/navigation systems.

Upstream

Innovation in materials and design is the core barrier. The manufacturing of puncture needles involves precision processing, specialized materials science, and bio-coating technology. The material of the needle tube (such as superelastic nickel-titanium alloy, stainless steel) determines its flexibility and strength; the geometric shape of the needle tip (such as triangular, sloping, or blunt) affects the puncture resistance and degree of tissue damage; the smoothness of the inner wall of the needle cavity directly affects the sampling efficiency. Additionally, a hydrophilic coating on the surface can reduce friction, and a hemostatic coating can lower the risk of bleeding. These are the value propositions of high-end puncture needles. The material science and precision processing capabilities in the upstream constitute the first technological moat of the industry.

Midstream

Expansion of product categories from "general instruments" to "integrated systems." The market has already gone beyond the simple biopsy needles and has developed a rich product portfolio:

• By function: It includes cell suction needles, tissue cutting needles, bone-drilling puncture needles (used for hard or calcified lesions), and treatment needles that combine biopsy and ablation.
• By guidance method: There are general-purpose puncture needles for CT guidance, as well as ultra-thin navigation puncture needles specifically designed for electromagnetic navigation bronchoscopy (ENB) and capable of operating through the bronchoscope's working channel.
• By technology: The coaxial cannula needle system has become the mainstream. Its "one sheath with multiple needles" design concept has improved surgical efficiency and safety standards.
• The competition among midstream manufacturers has shifted from the performance of individual products to the ability to provide comprehensive solutions for clinical use, including accompanying positioning markers, tissue sample processing solutions, and operational training.

Downstream

Clinical demand-driven and business model transformation. The downstream includes various hospitals, especially tertiary hospitals' departments of respiratory and critical care medicine, thoracic surgery, and interventional imaging. Their demands are directly driven by clinical trends:

• Popularization of early lung cancer screening: The number of lung nodules detected by low-dose spiral CT has increased significantly, driving the demand for minimally invasive diagnostic methods (biopsies).
• Urgent need for precision medicine: Molecular pathological testing requires more high-quality tissue samples, which has promoted the sales of large-sized, high-capture-rate biopsy needles.
• Development of day surgery: The outpatient and rapid biopsy process requires safer equipment and simpler operation, which has driven the market for disposable, highly reliable biopsy needles.

In the current market landscape, international giants such as Medtronic, Bard, and Boston Scientific have long dominated the high-end market due to their leading market position and technological accumulation. However, in recent years, domestic enterprises like Minerva, Nanmei, and Xinguangwei, through continuous research and development, have rapidly caught up in terms of product quality, innovative design (such as disposable electronic puncture navigation needles), and cost-effectiveness. The process of domestic substitution has significantly accelerated. At the same time, the "bundle sales" or "collaborative research and development" of puncture needles with imaging equipment such as CT, ultrasound, and electromagnetic navigation has become increasingly close, forming an "equipment + consumables + services" ecological competition.

In the future, with the application of surgical robot technology in the field of puncture, the market for intelligent puncture needles (capable of sensing force and providing feedback on resistance) will open up a new growth curve. This sector will continue to witness deep collisions and integration of technology, clinical practice, and business.